Esomeprazole (ESM) (Figure 1) is chemically, 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl] sulfi nyl}-1H-benzimidazole that has S confi guration at the sulfur atom. It is a proton pump inhibitor that decreases the amount of acid produced in the stomach. ESM is used to treat certain stomach and esophagus problems. It relieves symptoms such as heartburn, diffi culty swallowing, and persistent cough. This medication helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus [1] . ESM is combined with the antibiotics, clarithromycin and amoxicillin (or metronidazole in penicillin-hypersensitive patients) in the 7-14days eradication triple therapy for Helicobacter pylori. Infection by H. pylori is the causative factor in the majority of peptic and duodenal ulcers [2]. Literature survey demonstrated that few analytical techniques have been employed for the determination of ESM Abstract A novel simple, accurate, sensitive and economical spectrophotometric method has been established and validated for the determination of esomeprazole and ciprofl oxacin. The method is based on the oxidation of the studied drug by a known excess of potassium permanganate, followed by measuring the decrease in absorption (∆A) of KMnO 4 in acidic medium at wavelength of 525nm. The detection limit is reported to be 1.01 and 1.06μg/mL showing a high degree of sensitivity. The proposed method was successfully validated according to ICH guidelines for the determination of esomeprazole and ciprofl oxacin with a highly precise recovery and very low relative standard deviation. Finally, the method was compared statistically with a reference method showing equal accuracy, reproducibility and no signifi cant difference with the reported one.
such as spectrophotometry [1] [2] [3] [4] [5] [6] [7] [8] , liquid chromatography [8, 9] and spectrodensitometry method [10] .
Ciprofl oxacin (CIP) (Figure 1 ) is 1-cyclopropyl-6-fl uoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid. It is used to treat a variety of bacterial infections. CIP belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria [11] . Literature survey demonstrated that several analytical techniques have been employed for the determination of CIP such as different spectroscopic [11] [12] [13] [14] and chromatographic [15] [16] [17] [18] methods.
To our knowledge, no spectrophotometric method for the determination of ESM or CIP using potassium permenganate as an oxidant has yet been reported despite the versatility, simplicity and reliability of the technique in chemical analysis.
As such, in this paper, the method is based on an oxidation reaction of ESM and CIP with a known excess of KMnO 4 followed by measuring the decrease in absorption (∆A) of KMnO 4 in acidic medium at wavelength of 525nm. 
Experimental

Apparatus
Materials and reagents
All solvents and reagents were of analytical grade and double distilled water was used throughout the work. Sulfuric Acid (El-nasr chemical, Egypt) was prepared as 2M.
Pharmaceutical formulations
Esmatac ® 40mg was labeled to contain 40 mg esomeprazole (Egyptian group for pharmaceutical industries). Ciprocin ® 250mg was labeled to contain 250mg ciprofl oxacin (Egyptian Company for Pharmaceutical & Chemical Industries (EIPICO)). 
Spectrophotometric procedures
Results and discussions
Optimization of the reaction conditions
The optimum conditions for the method development were established by varying each specifi c parameter and keeping the others constant and observing the effect produced on the absorbance of the colored species. The optimum parameters are reported in Table 1 . 
Absorption spectra: Absorption spectra of ESM and CIP with
Effect of temperature
Effect of temperature was studied and results showed that there is no an evident effect of temperature on the reaction as increase in temperature is not accompanied with any increase in absorbance and so, optimum reaction was performed at room temperature. Effect of addition sequence: Addition sequences were studied and results revealed that the most appropriate sequence was the drug then the added acid then the added KMnO 4 .
Effect of acidity :
To study the effect of sulfuric acid volume, the reaction was performed in a series of 10mL volumetric fl asks containing different volumes (0.5-4ml) of 2M sulfuric acid. It was found that the maximum absorbance was obtained when using 1mL of 2M sulfuric acid with ESM and 1.50mL with CIP as seen in Figure 3 .
Effect of permenganate concentration: By studying the effect of KMnO 4 concentration referring to decrease of its color intensity, it was observed that the absorbance reached its maximum when 1mL of 5×10 -3 M KMnO 4 was used in case of both ESM and CIP (Figure 4 ).
Effect of time:
The effect of time on the oxidation reaction was studied to obtain the highest and most stable absorbance. As depicted in Figure 5 , This absorbance can be achieved immediately after the reaction between the drug and KMnO 4 in case of ESM while it takes 16 minutes in case of CIP to complete the reaction.
Method validation
The method validation was performed according to International Conference of Harmonization (ICH) guidelines [19] .
Linearity: Six different concentrations of ESM and CIP were prepared for linearity studies. The linearity ranges of absorbance as a function of drug concentration (Table 2) provided acceptable indication about sensitivity of reagents used. Linear regression equations of ESM and CIP were found to be y=0.0334x+0.0379 and y=0.0444x+0.2459, respectively and the regression coeffi cient values (R 2 ) were found to be 0.9994 and 0.9991, respectively indicating a high degree of linearity for both drugs (Figure 6 ).
Accuracy:
The accuracy of the method was determined by investigating the recovery of ESM and CIP concentration levels covering the specifi ed range using the standard addition technique. It was performed by adding a fi xed standard drug concentration at different levels of the pharmaceutical products (Esmatac ® and Ciprocin ® ) and the proposed method was followed. From the amount of the drug estimated, the percentage recovery was calculated and the results are shown in Table 3 .
Specifi city:
The specifi city studies revealed that the presence of the excipents in Esmatac ® 40mg and Ciprocin ® 250mg formulations didn't show any kind of impurity interference, since the recoveries lied in the range of 96.90-104.85% as reported in Table 3 .
Limits of detection and limits of quantifi cation:
The calculation of limits of detection and quantitation was based on the following equations: LOD=3.3S/K and LOQ=10S/K, respectively, where S is the standard deviation of the seven replicate values under the same conditions as for the sample analysis in the absence of analyte and K is the sensitivity, namely, the slope of calibration graph. Limits of detection were calculated to be 1.01 and 1.06μg/mL while limits of quantifi cation were 3.35 and 3.55μg/mL, for ESM and CIP respectively ( Table 2) .
Robustness:
The robustness of the method was evaluated by making small changes (±0.05ml) in the volume of H 2 SO 4 and KMnO 4 keeping the other conditions constant where the effect of the changes was studied on the percent recovery and standard deviation of 20μg/mL ESM and CIP. The changes had negligible infl uence on the results where SD values were in the acceptable range as reported in Table 4 . Ruggedness: The ruggedness of the method was tested by measuring three concentrations of the standard working solution using a different double beam spectrophotometer (model Jenway 6500, UK). The absorbances in case of the three procedures for both instruments were exactly similar indicating that the method is fairly rugged. According to ICH guidelines, the obtained values indicated high sensitivity of the proposed method.
Statistical analysis of the pharmaceutical formulation
Esmatac ® 40mg and Ciprocin ® 250mg have been successfully analyzed by the proposed method. Results obtained were compared to those obtained by applying reference methods [4, 11] 
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